LGND Stock Summary and Trading Ideas (Ligand Pharmaceuticals | NASDAQ:LGND)

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

What symbol and exchange does Ligand Pharmaceuticals shares trade?

Ligand Pharmaceuticals trades on the NASDAQ stock market under the symbol LGND.

What is Ligand Pharmaceuticals stock price doing today?

As of February 27, 2026, LGND stock price climbed to $198.31 with 192,017 million shares trading.

What is Ligand Pharmaceuticals's Beta?

LGND has a beta of 0.78, meaning it tends to be less sensitive to market movements. LGND has a correlation of 0.16 to the broad based SPY ETF.

How much is Ligand Pharmaceuticals worth?

LGND has a market cap of $3.90 billion. This is considered a Mid Cap stock.

How much money does Ligand Pharmaceuticals make?

Last quarter Ligand Pharmaceuticals reported $60 million in Revenue and $2.02 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.87.

What is the highest and lowest price Ligand Pharmaceuticals traded in the last 3 year period?

In the last 3 years, LGND traded as high as $212.49 and as low as $49.24.

What are the top ETFs holding Ligand Pharmaceuticals?

The top ETF exchange traded funds that LGND belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.

Is Ligand Pharmaceuticals (LGND) a good investment?

LGND has outperformed the market in the last year with a price return of +71.4% while the SPY ETF gained +18.5%. However, in the short term, LGND had mixed performance relative to the market. It has underperformed in the last 3 months, returning -3.8% vs +1.2% return in SPY. But in the last 2 weeks, LGND shares have fared better than the market returning +7.9% compared to SPY +0.6%.

What are the support and resistance levels for Ligand Pharmaceuticals (LGND)?

LGND support price is $190.53 and resistance is $201.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LGND shares will trade within this expected range on the day.